Omalizumab in asthma: Approval and postapproval experience

Clinical Reviews in Allergy and Immunology

Volumn 29, Issue 1, 2005, Pages 3-16

  Chiang, Dean T ^a   Clark, Justin ^a   Casale, Thomas B ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allergies; Anti IgE; Asthma; Omalizumab; Rhinitis

Indexed keywords

IMMUNOGLOBULIN E; OMALIZUMAB; PLACEBO;

ALLERGIC RHINITIS; ANTIGEN PRESENTING CELL; ASTHMA; BRONCHUS HYPERREACTIVITY; BURNING SENSATION; CELL TYPE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG APPROVAL; DRUG BINDING SITE; DRUG EFFECT; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; EDEMA; EXPERIENCE; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION SITE REACTION; LABORATORY TEST; META ANALYSIS; NONHUMAN; PHARYNGITIS; PNEUMONIA; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVIEW; SINUSITIS; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT WITHDRAWAL; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VIRUS INFECTION;

EID: 26444546331     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1385/criai:29:1:003     Document Type: Review

References (62)

1. Ishizaka, K., Ishizaka, T., and Terry, W. D. (1967), J. Immunol. 99, 849-858.
2. Sutton, B. J. and Gould, H. J. (1993), Nature 366, 421-428.
3. Hamelmann, E., Rolinck-Wernighaus, C., and Wahn, U. (2002), Allergy 57, 983-994.
4. MacGlashan, D., Lichtenstein, L. M., McKenzie-White, J., et al. (1999), J. Allergy Clin. Immunol. 104, 492-498.
5. Kisselgof, A. B. and Oettgen, H. C. (1998), Int. Immunol. 10, 1377-1384.
6. Tsicopoulos, A. and Joseph, M. (2000), Clin. Exp. Allergy 30, 602.
7. Presta, L. G., Lahr, S. J., Shields, R. L., et al. (1993), J. Immunol. 151, 2623-2632.
8. Shields, R. L., Werther, W. R., Zioncheck, K., et al. (1995), Int. Arch. Allergy Immunol. 107, 308-312.
9. Liu, J., Lester, P., Builder, S., and Shire, S. J. (1995), Biochemistry 34(33), 10,474-10,482.
10. Easthope, S. and Jarvis, B. (2001), Drugs 61, 253-260.
11. Omalizumab (Xolair): An anti-IgE antibody for asthma. In: The Medical Letter on Drugs and Therapeutics. The Medical Letter, Inc., New Rochelle, NY 2003; 45, 67.
12. MacGlashan, D. W. Jr., Bochner, B. S., Adelman, D. C., et al. (1997), J. Immunol. 158, 1438-1445.
13. Lin, H., Boesel, K. M., Griffith, D. T., et al. (2004), J. Allergy Clin. Immunol. 113, 297-302.
14. Prussin, C., Griffith, D. T., Boesel, K. M., et al. (2003), J. Allergy Clin. Immunol. 112, 1147-1154.
15. Maurer, D., Fiebiger, E., Reininger, B., et al. (1998), J. Immunol. 161, 2731-2739.
16. Rissoan, M. C., Soumelis, V., Kadowaki, N., et al. (1999), Science 283, 1183-1186.
17. Foster, B., Metcalfe, D. D., and Prussin, C. (2003), J. Allergy Clin. Immunol. 112, 1132-1138.
18. Beck, L. A., Marcotte, G. V., MacGlashan, D., Togias, A., and Saini, S. (2004), J. Allergy Clin. Immunol. 114, 527-530.
19. Ong, Y. E., Menzies-Gow, A., Matthews, J., and Kay, A. B. (2004), J. Allergy Clin. Immunol. 113(Suppl.), S84.
20. Togias, A., Corren, J., Shapiro, G., et al. (1998), J. Allergy Clin. Immunol. 101(Suppl.), S171.
21. Fahy, J. V., Flemin, H. E., Won, H. H., et al. (1997), Am. J. Respir. Crit. Care Med. 155, 1828-1834.
22. Boulet, L. P., Chapman, K. R., Cote, J., et al. (1997), Am. J. Respir. Crit. Care Med. 155, 1835-1840.
23. Noga, O., Hanf, G., and Kunkel, G. (2003), Int. Arch. Allergy Immunol. 131, 46-52.
24. Djukanovic, R., Wilson, S. J., Kraft, M., et al. (2004), Am. J. Respir. Crit. Care Med. 170, 583-593.
25. Joos, G. F., O'Connor, B., Anderson, S. D., et al. (2003), Eur. Respir. J. 21, 1050-1068.
26. Silkoff, P. E., McClean, P. A., Slutsky, A. S., et al. (1998), J. Asthma 35, 473-479.
27. Barnes, P. J. and Kharitonov, S. A. (1996), Thorax 51, 233-237.
28. Silkoff, P. E., Romero, F. A., Gupta, N., Townley, R. G., and Milgrom, H. (2004), Pediatrics 113, 308-312.
29. Milgrom, H., Fick, R. B., Su, J. Q., et al. (1999), N. Engl. J. Med. 341, 1966-1973.
30. Busse, W., Corren, J., Lanier, B. Q., et al. (2001), J. Allergy Clin. Immunol. 108, 184-190.
31. Milgrom, H., Berger, W., Nayak, A., et al. (2001), Pediatrics 108, E36.
32. Solér, M., Matz, J., Townley, R., et al. (2001), Eur. Respir. J. 18, 254-261.
33. Package insert. Xolair (omalizumab). East Hanover, NJ: Aventis, June 2003.
34. Prescribing information: summary of product characteristics. Available at: http://www.xolair.com. Last accessed: January 2005.
35. Brownell, J. and Casale, T. B. (2004), Immunol. Allergy Clin. N. Am. 24, 551-568.
36. Corren, J., Casale, T. B., Deniz, Y., et al. (2003), J. Allergy Clin. Immunol. 111, 87-90.
37. Bousquet, J., Wenzel, S., Holgate, S., et al. (2004), Chest 125, 1378-1386.
38. Holgate, S. T., Chuchalin, A. G., Hebert, J., et al. (2004), Clin. Exp. Allergy 34, 632-638.
39. Ayres, J. G., Higgins, B., Chilvers, E. R., Ayre, G., Blogg, M., and Fox, H. (2004), Allergy 59, 701-708.
40. Oba, Y. and Salzman, G. A. (2004), J. Allergy Clin. Immunol. 114, 265-269.
41. Bousquet, J., Cabrera, P., Berkman, N., et al. (2005), Allergy 60, 302-308.
42. Humbert, M., Beasley, R., Ayres, J., et al. (2005), Allergy 60, 309-316.
43. Dykewicz, M. S. and Fineman, S. (1998), Ann. Allergy Asthma Immunol. 81, 478-518.
44. Blaiss, M. S. (1999), Ann. Allergy Asthma. Immunol. 83, 449-454.
45. Bousquet, J., van Cauwenberge, P., and Khaltaev, N. (2001), J. Allergy Clin. Immunol. 108, S147-S336.
46. Dykewicz, M. S. (2001), Immunol. Allergy Clin. N. Am. 21, 427.
47. Greenberger, P. A. (2004), Allergy Asthma Proc. 25, 89-93.
48. Corren, J., Manning, B. E., Thompson, S. F., et al. (2004), J. Allergy Clin. Immunol. 113, 415-419.
49. Adelroth, E., Rak, S., Haahtela, T., et al. (2000), J. Allergy Clin. Immunol. 106, 253-259.
50. Casale, T. B., Condemi, J., LaForce, C., et al. (2001), JAMA 286, 2956-2967.
51. Chervinsky, P., Casale, T., Townley, R., et al. (2003), Ann. Allergy Asthma Immunol. 91, 160-167.
52. Hanf, G., Noga, O., O'Connor, A., and Kunkel, G. (2004), Eur. Respir. J. 23, 414-418.
53. Vignola, A. M., Humbert, M., Bousquet, J., et al. (2004), Allergy 59, 709-717.
54. Schoenwetter, W., Gupta, N., Liu, J., et al. (2002), Eur. Respir. J. 20(Suppl 38), [abstract] P741.
55. Berger, W., Gupta, N., McAlary, M., et al. (2003), Ann. Allergy Asthma Immunol. 91, 182-188.
56. Casale, T. B. (2001), J. Allergy Clin. Immunol. 108(2), S84-S88.
57. Heusser, C. and Jardieu, P. (1997), Curr. Opin. Immunol. 9, 805-814.
58. Shields, R. L., Werther, W. R., Zioncheck, K., et al. (1995), Int. Arch. Allergy Immunol. 107, 412,413.
59. Schoenhoff, M., Lin, Y., Froehlich, J., Fick, R., and Bates, D. (1995), Pharm. Res. 12, 411.
60. Fox, J. A., Hotaling, T. E., Struble, C., et al. (1996), J. Pharmacol. Exp. Ther. 279, 1000-1008.
61. Casale, T. B., Kline, J. N., Busse, W. W., et al. (2005), J. Allergy Clin. Immunol. 115(2), S65.
62. Kline, J. N., Casale, T. B., Busse, W. W., et al. (2005), J. Allergy Clin. Immunol. 115(2), S207.